Articles tagged with Cancer Treatments
A study by Helmholtz Munich researchers identified a key role of the protein BMP7 in promoting cell division and migration in pheochromocytoma cells. Targeting this signaling pathway with specific substances may lead to an increase in apoptosis, providing a new approach for treatment.
Daily changes in nuclear positioning of circadian genes regulate their activity with a 24-hour period. Researchers identified two proteins PARP1 and CTCF that bring genes to the periphery, promoting silent state.
The discovery reveals protein structural changes that could inform treatments for inflammatory conditions such as heart disease and colon cancer. The researchers found that two proteins, Tollip and Tom1, work together to regulate the turnover of cell-surface receptor proteins that trigger inflammation.
The study reveals that the mutation disrupts normal cell function by interfering with RNA and protein movement into and out of the nucleus. This leads to neuronal deterioration and death in the brain and spinal cord, causing loss of voluntary muscle movement, paralysis, and respiratory failure.
A study by German Cancer Research Center discovered that citric acid from lemon juice can alter the morphology of norovirus particles, reducing their infectivity. The researchers found that citrate binds to specific proteins on the virus, preventing it from attaching to host cells.
A nine-gene molecular prognostic index (MPI) provides accurate survival stratification for early-stage non-small cell lung cancer (NSCLC) patients. The MPI combines gene expression profiles with clinical data from a large database, enabling robust and clinically applicable predictions.
Researchers found that powdered cranberry combats colon cancer in mice by reducing tumor size and number. The study suggests that individual components of the fruit could lead to a better understanding of its anti-cancer potential, potentially leading to more effective treatments for colon cancer.
Rice University bioengineers have developed a technique called progeny clustering that clarifies big data clusters, enabling doctors to design personalized treatments. The algorithm increases the size of data sets and reveals distinct patterns, allowing for more accurate cluster grouping.
A recent study published in The Annals of Thoracic Surgery found that patients with suspected lung cancer often wait too long to receive treatment and skip vital diagnostic steps. Only 1 in 10 patients had the recommended combination of three staging tests before surgery, highlighting the need for improved quality care.
A $1.5 million gift will support research in spinal muscular atrophy with respiratory distress (SMARD), a rare condition affecting fewer than 70 reported cases worldwide. The funding will enable the development of effective treatments and therapies for children impacted by this devastating disease.
Researchers discovered that patients with detectable HPV16 DNA in their saliva after cancer treatment are more likely to develop cancer recurrence. The finding could lead to earlier detection and better prognosis for these patients, enabling them to receive timely treatment options.
A study of over 70,000 cancer patients found that those referred late by their GP were more likely to be dissatisfied with their care. Patients who experienced referral delays reported negative experiences across various aspects of their care, including diagnosis and treatment.
The study found that persistent HPV16 DNA detection after treatment was associated with worse disease-free survival and overall survival. This could be a useful tool for long-term tumor surveillance, potentially reducing the need for costly imaging and intensifying visits.
Researchers have identified five distinct types of prostate cancer with unique genetic fingerprints, which could help doctors predict the aggressiveness of tumors and choose the best course of treatment. This breakthrough discovery has important implications for how prostate cancer is diagnosed and treated in the future.
Researchers discovered a small RNA molecule called miR-148a plays a role in lung cancer resistance to TRAIL, and inhibiting NF-κB makes it more effective. This study suggests a way to overcome resistance and develop new treatments for lung cancer.
A new study shows that children with cancer can benefit from adapted physical activities, such as dog sledding, which improves their physical and psychological health. The expedition successfully completed by the children demonstrated statistically significant improvement in both areas.
A metagenome-wide association study uncovered markers in the oral and gut microbiomes that are associated with rheumatoid arthritis (RA). The study found that Haemophilus sp. is depleted in RA patients and Lactobacillus salivarius is over-represented, suggesting potential new targets for diagnosis and treatment.
A new study found that young cancer patients often have limited knowledge about fertility preservation options, which can impact their treatment plans. Males are more likely to discuss fertility preservation with clinicians than females, but both sexes face barriers such as lack of insurance coverage and education.
Researchers at Scripps Research Institute will explore therapeutic potential of proteins regulating human health and associated diseases like Parkinson's and arthritis.
Telomeres, protective caps on chromosome ends, have been linked to numerous illnesses, including many types of cancer. Their shortening is associated with ageing and tissue regeneration issues, but cancer cells can repair them using telomerase.
The Paul G. Allen Family Foundation has awarded $7 million to five research teams to investigate the fundamental causes of Alzheimer's disease. The projects will focus on uncovering the biological roots of the disease, including gene combinations, white matter damage, and pH levels.
Researchers discovered that age affects the interaction between Interleukin-2 and human mesenchymal stem cells. In younger patients, IL-2 and MSCs work together to fight cancer, but older populations see impaired treatment outcomes.
A study found a correlation between abnormal noninvasive prenatal testing (NIPT) results and subsequent maternal cancer diagnoses. Occult malignancies may explain discordant NIPT results, highlighting the need for diagnostic procedures to determine fetal karyotypes.
A large trial shows liquid biopsy (BEAMing technology) detects tumor genotypes not found in tissue biopsies, enabling targeted therapy selection. Regorafenib benefits patients with KRAS and PIK3CA mutations, revolutionizing colorectal cancer treatment.
A new study found that cancer survivors may face limited options for adoption due to agency policies, but a training program for oncology healthcare providers can provide valuable information. Cancer survivors often turn to adoption due to infertility caused by cancer treatments, but the process is long and costly.
The International Society for Sexual Medicine recommends a clinical and biochemical syndrome definition for testosterone deficiency, characterized by low testosterone levels and symptoms. The new guidelines provide evidence-based guidance on testing, lifestyle modifications, and treatment options for men with testosterone deficiency.
Researchers have found a way to separate cannabis' medical benefits from its negative effects by blocking a specific pathway. This breakthrough could lead to safe cannabis-based therapies that preserve pain relief and memory function.
The foundation named four young scientists to tackle cancers in children and young adults. The fellowship award will provide nearly $875,000 to support their research over four years.
The Lymphoma Epidemiology of Outcomes Cohort Study will enroll 12,000 NHL patients and follow them for long-term prognosis and survivorship. The grant aims to improve the length and quality of life for NHL survivors.
A joint study by IRB Barcelona researchers reveals CEP63's crucial role in brain cell division and sperm production, providing new insights into Seckel Syndrome and microcephaly. The protein's inhibition may lead to therapeutic approaches for treating these conditions.
Rates of active surveillance for low-risk prostate cancer increased sharply from 2010 to 2013, while high-risk disease was treated more appropriately with local treatments. Treatment patterns varied across individual practices, but suggest a genuine change in prostate cancer management in the US.
A UCLA review of common practices in prostate cancer has found that monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance is an effective approach for many patients. This approach could spare them the debilitating side effects of aggressive treatments, which are often used unnecessari...
A meta-analysis found that cognitive behavioral therapy for insomnia was associated with reduced insomnia symptoms and sleep disturbances in individuals with coexisting psychiatric and medical conditions. Patients who received cognitive behavioral therapy had twice the percentage of remission from insomnia compared to control groups.
A new study by the American Cancer Society found that cancer survivors who currently smoke report fewer negative opinions about smoking and have more barriers to quitting. They are also more likely to be exposed to other smokers, which may contribute to continued smoking.
Researchers have identified specific genetic mutations in patients with aplastic anemia that can help doctors optimize treatment. The study, which analyzed over 400 patient genomes, found that certain mutations are associated with poorer long-term outcomes and increased risk of blood cancers.
A new detection method has been developed to rapidly and accurately detect drug-resistant HCV mutants, including the Y93H mutation. The system achieved a high success rate of 98.9% in detecting this mutation in Japanese HCV genotype 1b patients.
A small molecule agent PSMA-617 specifically attaches to prostate-specific membrane antigen on cancer cells, allowing for early detection of secondary tumors and monitoring response to therapy. This agent has shown promising results in PET scans and holds potential as a therapeutic option for hormone-resistant prostate carcinoma.
The American College of Cardiology seeks to expand cardio-oncology services to address the growing need for specialized care in cardiovascular health for cancer patients. Currently, many hospital training programs lack formal training or services in this area, and a nationwide survey reveals gaps in resources and best practices.
Researchers at St. Jude Children's Research Hospital have found a way to prevent or slow progression of colorectal cancer by boosting the activity of a protective gene called AIM2 and giving patients healthy donor bacteria.
A Vanderbilt-led study found a 28% decline in new prostate cancer diagnoses in the U.S. following the USPSTF's recommendation to discontinue routine PSA screenings. This decrease was observed mainly among low-risk cancers and men over age 70.
Leading researchers from Canada and Israel are working together to uncover the molecular landscape of pancreatic cancer and develop new biomarkers for detection and diagnostics. The collaboration aims to improve patient outcomes by discovering targeted therapies.
Researchers at Helmholtz Zentrum München have found that the viral protein LMP2A helps EBV-infected cells evade immune detection. This may contribute to the development of cancer, particularly in nasopharyngeal carcinoma and Hodgkin's lymphoma.
A dose reduction strategy for TNF inhibitors can maintain good clinical response in RA patients even when the dose is reduced by one-third. Reducing the dose by two-thirds results in more flares, but these subsided when the higher dose was restarted.
Fatigue remains a debilitating problem for RA patients, with healthcare professionals often failing to measure it. New guidelines recommend validated fatigue measurements to improve patient outcomes. In contrast, treatment aimed at achieving disease remission is unlikely to be effective in addressing fatigue.
A new study by Cancer Research UK found that breast cancer patients are disproportionately affected, with only 20% having surgery after an emergency diagnosis in hospital. In contrast, those diagnosed via urgent GP referrals have a much higher likelihood of receiving lifesaving surgery.
Abelardo Colon and Jennifer Gill from the University of Puerto Rico won the top honors with their video explaining a new method for disinfecting drinking water using a nanodiamond powder. The process has promising results, reducing fecal E. coli colonies and increasing density.
Research from Brigham and Women's Hospital suggests that breast surgery for low-grade DCIS does not significantly change patient survival rates. For high- and intermediate-grade DCIS, however, surgery improves survival rates compared to non-surgery groups.
Researchers have developed a novel delivery strategy using an aptamer to introduce functional microRNAs into cells, targeting breast cancer and blood vessel cells. The therapy shows anti-cancer and angiogenic activities, inhibiting tumor growth and protecting against atherosclerosis.
The combination of MEDI4736 and tremelimumab has been shown to have manageable toxicity and clinical activity in advanced NSCLC patients, including those with PD-L1 negative tumors. Eight out of 31 evaluable patients achieved a partial response.
A new clinical study published in The Lancet shows that augmentation therapy can preserve lung structure and add years of life for patients with alpha-1 antitrypsin deficiency. The treatment has been found to be effective in slowing the progression of emphysema in severe cases.
A phase I study of ruxolitinib found no dose-limiting toxicities and improved symptoms in 15 evaluable CMML patients. Hematologic improvement and partial responses were observed, particularly in patients with B symptoms.
The American Association for Cancer Research (AACR) has partnered with Bayer HealthCare to expand its Basic Cancer Research Fellowship Program. The partnership aims to support young scientists conducting basic cancer research, addressing the current funding crisis in biomedical research.
A machine learning breakthrough enables fast and accurate measurement of metabolic profiles from biofluid samples, revolutionizing predictive medical screening. This technology accelerates the development of diagnostic tests for various diseases, potentially years before symptoms appear.
A University of Miami researcher has received a $1.9 million grant to investigate the impact of cognitive behavioral therapy (CBT) on smoking cessation in African American, Hispanic and White smokers. The study aims to reduce tobacco-associated health disparities by examining the effects of CBT on stress and depressive symptoms.
A two-year study found that female breast cancer survivors lost an average of 6% of their body weight through lifestyle changes, which may lower the risk of cancer recurrence. The study's results suggest that modest weight loss could become a routine part of oncology care to improve patient outcomes.
Researchers at the University of Minnesota Academic Health Center have developed a new genetic mouse model that reveals genes and pathways driving osteosarcoma. The model identifies SEMA4D and SEMA6D as key proteins to target in osteosarcoma treatment.
A study published in Nature Communications reveals that a specific type of non-coding RNA, known as Eleanors, plays a key role in the development of endocrine therapy resistance in ER-positive breast cancer cells. Resveratrol was found to repress these RNAs, inhibiting the proliferation of resistant cancer cells.
Patients aged 80 and above are significantly less likely to be investigated or aggressively treated after surgery than their younger counterparts. This is despite the fact that the oldest old have higher rates of trauma and multiple underlying conditions on admission.
A study found that 38% of lung cancer survivors developed recurrent or new cancer during a 8.3-year surveillance period. Key risk factors for recurrence included smoking status, prior cancers, and asbestos exposure, highlighting the need for close monitoring and quitting smoking to reduce cancer recurrence.
J. Paul Taylor has been selected as a Howard Hughes Medical Institute (HHMI) investigator, recognizing his expertise in cell and molecular biology, neurological diseases, and genetics. The HHMI initiative will provide Taylor with salary, benefits, and a research budget to accelerate his work on groundbreaking scientific contributions.